- Home
- News
- Topics
- FDA Week
- Inside CMS
- Inside Drug Pricing
- Health Exchange Alert
- Inside TeleHealth
- About Us
Despite a White House listening session last week asking for insight from stakeholders on how to address the role of pharmacy benefit managers (PBMs) in high prescription drug prices, the president’s State of the Union Address a few days later and his 2025 budget request this week are silent on PBM reform -- and PBM reform advocates are calling for action.
Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.
Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.
© 2002-2025. Inside Washington Publishers | Contact Us